Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.
- J. Li, D. Sexton, +5 authors G. Corey
- Clinical infectious diseases : an official…
- 1 April 2000
Modifications of the Duke criteria for the diagnosis of infective endocarditis are proposed, including that positive Q-fever serology should be changed to a major criterion and the minor criterion "echocardiogram consistent with IE but not meeting major criterion" should be eliminated. Expand
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.
In the early 21st century, IE is more often an acute disease, characterized by a high rate of S aureus infection, and Mortality remains relatively high. Expand
Staphylococcus aureus endocarditis: a consequence of medical progress.
Characteristics of patients with S aureus IE vary significantly by region, and further studies are required to determine the causes of regional variation. Expand
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
- V. Fowler, H. Boucher, +23 authors S. Cosgrove
- The New England journal of medicine
- 17 August 2006
Daptomycin (6 mg per kilogram daily) is not inferior to standard therapy for S. aureus bacteremia and right-sided endocarditis and met prespecified criteria for the noninferiority of daptomecin. Expand
Extra‐Intestinal Manifestations of Salmonella Infections
The mortality rate for patients in this series was considerably lower than the rate described for focal infections in other reviews, and specific guidelines for surgical removal of infected aneurysms have been proposed and these may be responsible for higher survival rates in recent years. Expand
Clinical identifiers of complicated Staphylococcus aureus bacteremia.
Readily available clinical variables can help identify patients at risk for complicated SAB. Expand
Epidemiology of methicillin-resistant Staphylococcus aureus.
The trends in both nosocomial and community-associated MRSA infections are examined and recent studies of the mechanisms that allow S. aureus to become resistant to currently available drugs are explored. Expand
Contemporary clinical profile and outcome of prosthetic valve endocarditis.
Staphylococcus aureus is now the leading cause of Prosthetic valve endocarditis, and health care-associated infection significantly influences the clinical characteristics and outcome of PVE. Expand
Changing patient characteristics and the effect on mortality in endocarditis.
Staphylococcus aureus has emerged as a dominant cause of IE, and is an independent predictor of mortality, in patients with definite or possible IE at Duke University Medical Center from 1993 to 1999. Expand
Clinical Predictors of Major Infections After Cardiac Surgery
- V. Fowler, S. O'Brien, L. Muhlbaier, G. Corey, T. Ferguson, E. Peterson
- 30 August 2005
A model that can identify patients undergoing cardiac surgery who are at high risk for major infection is identified and validated, and these high-risk patients may be targeted for perioperative intervention strategies to reduce rates of major infection. Expand